Occudo Quantitative Strategies’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-4,102
| Closed | -$451K | – | 1287 |
|
|
2022
Q4 | $451K | Sell |
4,102
-22,533
| -85% | -$2.48M | 0.05% | 537 |
|
|
2022
Q3 | $1.57M | Buy |
26,635
+16,702
| +168% | +$986K | 0.12% | 251 |
|
|
2022
Q2 | $280K | Buy |
9,933
+4,573
| +85% | +$129K | 0.02% | 811 |
|
|
2022
Q1 | $202K | Buy |
+5,360
| New | +$202K | 0.02% | 942 |
|